Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Recurrent Lung Cancer

NCT05632913 is registered in ClinicalTrials.gov with Alpha Tau Medical LTD. as lead sponsor.

NCT NCT05632913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05632913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Recurrent Lung Cancer
Lead sponsor
Alpha Tau Medical LTD.
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2023
Completion date
February 28, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, recurrent lung cancer